Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Tiny study aims to predict which throat lesions turn cancerous

NCT ID NCT07508319

First seen Apr 06, 2026 · Last updated Jun 23, 2026 · Updated 13 times

Summary

This study looks at genetic and immune changes in laryngeal dysplasia, a precancerous condition of the voice box. Researchers will compare tissue samples from 3 patients to see if certain immune cells (TILs) differ between low-risk and high-risk lesions. The goal is to find markers that predict progression to cancer, which could improve monitoring and early treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD & NECK CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • European Institute of Oncology

    RECRUITING

    Milan, MI, 20141, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this research could help identify which patients with laryngeal dysplasia are at highest risk of developing cancer, enabling earlier intervention.

What could go wrong

This is a very small, early observational study with only 3 participants. It is not testing a treatment, so it may not lead directly to any new therapy or change in care.

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.